Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04913220
Title A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sanofi


skin squamous cell carcinoma


Cemiplimab + THOR-707

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU

No variant requirements are available.